Discovery of 4-alkoxy-6-methylpicolinamide negative allosteric modulators of metabotropic glutamate receptor subtype 5

被引：5

作者：

Felts, Andrew S. ^{[1
,2
]}

Bollinger, Katrina A. ^{[1
,2
]}

Brassard, Christopher J. ^{[1
,2
]}

Rodriguez, Alice L. ^{[1
,2
]}

Morrison, Ryan D. ^{[1
,2
]}

Daniels, J. Scott ^{[1
,2
]}

Blobaum, Anna L. ^{[1
,2
]}

Niswender, Colleen M. ^{[1
,2
,5
]}

Jones, Carrie K. ^{[1
,2
,5
]}

Conn, P. Jeffrey ^{[1
,2
,5
]}

Emmitte, Kyle A. ^{[1
,2
,5
,6
]}

Lindsley, Craig W. ^{[1
,2
,3
,4
]}

机构：

[1] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Med Ctr, Nashville, TN 37232 USA

[2] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA

[3] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA

[4] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA

[5] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Sch Med, Nashville, TN 37232 USA

[6] Univ North Texas Hlth Sci Ctr, UNT Syst Coll Pharm, Dept Pharmaceut Sci, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 01期

关键词：

mGlu(5); Metabotropic glutamate receptor; Negative allosteric modulator (NAM); CNS; Structure-Activity Relationship (SAR); BASIMGLURANT; ANTAGONISTS; MGLU(5); POTENT; IDENTIFICATION; REINFORCEMENT; REINSTATEMENT; PHARMACOLOGY; MAVOGLURANT; VU0424238;

D O I：

10.1016/j.bmcl.2018.11.017

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This letter describes the further chemical optimization of VU0424238 (auglurant), an mGlu(5) NAM clinical candidate that failed in non-human primate (NHP) 28 day toxicology due to accumulation of a species-specific aldehyde oxidase (AO) metabolite of the pyrimidine head group. Here, we excised the pyrimidine moiety, identified the minimum pharmacophore, and then developed a new series of saturated ether head groups that ablated any AO contribution to metabolism. Putative back-up compounds in this novel series provided increased sp(3) character, uniform CYP450-mediated metabolism across species, good functional potency and high CNS penetration. Key to the optimization was a combination of matrix and iterative libraries that allowed rapid surveillance of multiple domains of the allosteric ligand.

引用

页码：47 / 50

页数：4

共 50 条

[31] Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function
Noetzel, Meredith J.
Rook, Jerri M.
Vinson, Paige N.
Cho, Hyekyung P.
Days, Emily
Zhou, Y.
Rodriguez, Alice L.
Lavreysen, Hilde
Stauffer, Shaun R.
Niswender, Colleen M.
Xiang, Zixiu
Daniels, J. Scott
Jones, Carrie K.
Lindsley, Craig W.
Weaver, C. David
Conn, P. Jeffrey
MOLECULAR PHARMACOLOGY, 2012, 81 (02) : 120 - 133
[32] Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2
Felts, Andrew S.
Rodriguez, Alice L.
Smith, Katrina A.
Engers, Julie L.
Morrison, Ryan D.
Byers, Frank W.
Blobaum, Anna. L.
Locuson, Charles W.
Chang, Sichen
Venable, Daryl F.
Niswender, Colleen M.
Daniels, J. Scott
Conn, P. Jeffrey
Lindsley, Craig W.
Emmitte, Kyle A.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (22) : 9027 - 9040
[33] Synthesis and optimization of 4,5,6,7-tetrahydrooxazolo[4,5-c] pyridines as potent and orally-active metabotropic glutamate receptor 5 negative allosteric modulators
Hirose, Wataru
Kato, Yoshihiro
Natsutani, Itaru
Takata, Makoto
Kitaichi, Maiko
Imai, Satoki
Hayashi, Shun
Arai, Yukiyo
Hoshino, Kohei
Yoshida, Kohzo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (18) : 4331 - 4335
[34] Tetrahydronaphthyridine and Dihydronaphthyridinone Ethers As Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 5 (mGlu5)
Turlington, Mark
Malosh, Chrysa
Jacobs, Jon
Manka, Jason T.
Noetzel, Meredith J.
Vinson, Paige N.
Jadhav, Satyawan
Herman, Elizabeth J.
Lavreysen, Hilde
Mackie, Claire
Bartolome-Nebreda, Jose M.
Conde-Ceide, Susana
Luz Martin-Martin, M.
Min Tong, Han
Lopez, Silvia
MacDonald, Gregor J.
Steckler, Thomas
Daniels, J. Scott
Weaver, C. David
Niswender, Colleen M.
Jones, Carrie K.
Conn, P. Jeffrey
Lindsley, Craig W.
Stauffer, Shaun R.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (13) : 5620 - 5637
[35] Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia
Fraley, Mark E.
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (09) : 1259 - 1275
[36] Design, Synthesis, and Structure-Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5
Burdi, Douglas F.
Hunt, Rachel
Fan, Lei
Hu, Tao
Wang, Jun
Guo, Zihong
Huang, Zhiqiang
Wu, Chengde
Hardy, Larry
Detheux, Michel
Orsini, Michael A.
Quinton, Maria S.
Lew, Robert
Spear, Kerry
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (19) : 7107 - 7118
[37] Discovery of 2-(2-Benzoxazoyl amino)-4-Aryl-5-Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound
Mueller, Ralf
Dawson, Eric S.
Meiler, Jens
Rodriguez, Alice L.
Chauder, Brian A.
Bates, Brittney S.
Felts, Andrew S.
Lamb, Jeffrey P.
Menon, Usha N.
Jadhav, Sataywan B.
Kane, Alexander S.
Jones, Carrie K.
Gregory, Karen J.
Niswender, Colleen M.
Conn, P. Jeffrey
Olsen, Christopher M.
Winder, Danny G.
Emmitte, Kyle A.
Lindsley, Craig W.
CHEMMEDCHEM, 2012, 7 (03) : 406 - 414
[38] Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2
Lundstrom, L.
Bissantz, C.
Beck, J.
Dellenbach, M.
Woltering, T. J.
Wichmann, J.
Gatti, S.
NEUROPHARMACOLOGY, 2017, 115 : 115 - 127
[39] Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric Modulators
Sheffler, Douglas J.
Pinkerton, Anthony B.
Dahl, Russell
Markou, Athina
Cosford, Nicholas D. P.
ACS CHEMICAL NEUROSCIENCE, 2011, 2 (08): : 382 - 393
[40] Recent progress in the discovery and development of negative allosteric modulators of mGluR5
Lindsley, Craig W.
Emmitte, Kyle A.
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 446 - 457

← 1 2 3 4 5 →